Found: 68
Select item for more details and to access through your institution.
Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1011, doi. 10.1002/ajh.24827
- By:
- Publication type:
- Article
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 259, doi. 10.1002/ajh.24631
- By:
- Publication type:
- Article
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolution.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-0756-0
- By:
- Publication type:
- Article
Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- Oncologist, 2015, v. 20, n. 1, p. 50, doi. 10.1634/theoncologist.2014-0187
- By:
- Publication type:
- Article
Real-World Efficacy Outcomes of FLT3-ITD mut Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 154, doi. 10.1016/j.clml.2022.11.012
- By:
- Publication type:
- Article
Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e116, doi. 10.1016/j.clml.2021.08.014
- By:
- Publication type:
- Article
LDH and Renal Function are Prognostic factors for Long-term Outcomes of Multiple Myeloma Patients undergoing Allogeneic Hematopoietic Stem Cell: a Cohort of 100 Recipients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e301, doi. 10.1016/j.clml.2019.09.494
- By:
- Publication type:
- Article
Blocking of WIP1 Phosphatase Overcomes Bortezomib Resistance and Promotes Cell Death via ER Stress-induced Apoptotic JNK/c-Jun Signaling: Novel Therapeutic Target in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e102, doi. 10.1016/j.clml.2019.09.168
- By:
- Publication type:
- Article
Blocking of Transient Receptor Potential Vanilloid1 (TRPV1) Promotes Lysosomal Destabilization and Enhances Bortezomib-induced ER Stress and Cell Death via HSP70 and LAMP3 Down-regulation: Novel Therapeutic Target for Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e103, doi. 10.1016/j.clml.2019.09.169
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 6, p. 613, doi. 10.1159/000515902
- By:
- Publication type:
- Article
Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study.
- Published in:
- Acta Haematologica, 2015, v. 135, n. 1, p. 29, doi. 10.1159/000435769
- By:
- Publication type:
- Article
Novel Immunosuppression Compounds and Experimental Therapies for Chronic Graft-Versus-Host Disease.
- Published in:
- Acta Haematologica, 2013, v. 130, n. 1, p. 34, doi. 10.1159/000345836
- By:
- Publication type:
- Article
Changes in Gene Expression Pattern following Granulocyte Colony-Stimulating Factor Administration to Normal Stem Cell Sibling Donors.
- Published in:
- Acta Haematologica, 2007, v. 117, n. 2, p. 68, doi. 10.1159/000096856
- By:
- Publication type:
- Article
Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning.
- Published in:
- Acta Haematologica, 2004, v. 112, n. 1/2, p. 93, doi. 10.1159/000077564
- By:
- Publication type:
- Article
Second Malignancies after Hematopoietic Stem Cell Transplantation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 6, p. 863, doi. 10.1002/cncr.29141
- By:
- Publication type:
- Article
A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4706, doi. 10.1002/cncr.27418
- By:
- Publication type:
- Article
Allogenic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning in Patients With Refractory and Recurrent Multiple Myeloma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 15, p. 3621, doi. 10.1002/cncr.25228
- By:
- Publication type:
- Article
Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients.
- Published in:
- Transfusion Medicine & Hemotherapy, 2023, v. 50, n. 5, p. 456, doi. 10.1159/000529595
- By:
- Publication type:
- Article
Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion.
- Published in:
- American Journal of Hematology, 1998, v. 59, n. 4, p. 316, doi. 10.1002/(SICI)1096-8652(199812)59:4<316::AID-AJH9>3.0.CO;2-D
- By:
- Publication type:
- Article
Vibrio vulnificus sepsis associated with coincidental diagnosis of acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 1998, v. 58, n. 3, p. 252, doi. 10.1002/(SICI)1096-8652(199807)58:3<252::AID-AJH24>3.0.CO;2-A
- By:
- Publication type:
- Article
Burkitt's lymphoma in a patient with recurrent pericarditis.
- Published in:
- American Journal of Hematology, 1996, v. 51, n. 2, p. 175, doi. 10.1002/(SICI)1096-8652(199602)51:2<175::AID-AJH19>3.0.CO;2-H
- By:
- Publication type:
- Article
Recurrent 'Retinoic acid syndrome' during induction of remission in acute promyelocytic leukemia.
- Published in:
- American Journal of Hematology, 1995, v. 48, n. 3, p. 207, doi. 10.1002/ajh.2830480316
- By:
- Publication type:
- Article
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00479-3
- By:
- Publication type:
- Article
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0251-3
- By:
- Publication type:
- Article
CMV Seropositive Status Increases Heparanase SNPs Regulatory Activity, Risk of Acute GVHD and Yield of CD34 + Cell Mobilization.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 12, p. 3489, doi. 10.3390/cells10123489
- By:
- Publication type:
- Article
The HPSE Gene Insulator—A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2523, doi. 10.3390/cells10102523
- By:
- Publication type:
- Article
Contemporary evaluation of acute myeloid leukemia patients with long‐term survival exceeding 5 years.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 765, doi. 10.1111/ejh.13864
- By:
- Publication type:
- Article
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 2, p. 260, doi. 10.1111/ejh.13544
- By:
- Publication type:
- Article
Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 4, p. 402, doi. 10.1111/ejh.13299
- By:
- Publication type:
- Article
OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 4, p. 283, doi. 10.1111/ejh.12235
- By:
- Publication type:
- Article
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 3, p. 206, doi. 10.1111/j.1600-0609.2012.01811.x
- By:
- Publication type:
- Article
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01366-5
- By:
- Publication type:
- Article
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 4, p. 200, doi. 10.1002/hon.2005
- By:
- Publication type:
- Article
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00993-0
- By:
- Publication type:
- Article
BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 8, p. 1246, doi. 10.1002/cncr.33338
- By:
- Publication type:
- Article
Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 884, doi. 10.1111/bjh.17918
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 417, doi. 10.1111/bjh.17817
- By:
- Publication type:
- Article
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 767, doi. 10.1111/bjh.15973
- By:
- Publication type:
- Article
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 2, p. 172, doi. 10.1111/bjh.12013
- By:
- Publication type:
- Article
Outcome Differences in Patients with Precursor B Cell Acute Lymphocytic Leukemia Over Time: A Retrospective Analysis.
- Published in:
- Israel Medical Association Journal, 2014, v. 16, n. 4, p. 224
- By:
- Publication type:
- Article
Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0033856
- By:
- Publication type:
- Article
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: Non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.
- Published in:
- Current Oncology Reports, 2000, v. 2, n. 2, p. 132, doi. 10.1007/s11912-000-0084-y
- By:
- Publication type:
- Article
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1037, doi. 10.1007/s00277-023-05158-w
- By:
- Publication type:
- Article
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 3, p. 581, doi. 10.1007/s00277-021-04738-y
- By:
- Publication type:
- Article
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 309, doi. 10.1007/s00277-021-04716-4
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 379, doi. 10.1007/s00277-021-04693-8
- By:
- Publication type:
- Article